IBDEI0IH ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8298,0)
 ;;=N45.2^^55^537^50
 ;;^UTILITY(U,$J,358.3,8298,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8298,1,3,0)
 ;;=3^Orchitis
 ;;^UTILITY(U,$J,358.3,8298,1,4,0)
 ;;=4^N45.2
 ;;^UTILITY(U,$J,358.3,8298,2)
 ;;=^86174
 ;;^UTILITY(U,$J,358.3,8299,0)
 ;;=N45.1^^55^537^18
 ;;^UTILITY(U,$J,358.3,8299,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8299,1,3,0)
 ;;=3^Epididymitis
 ;;^UTILITY(U,$J,358.3,8299,1,4,0)
 ;;=4^N45.1
 ;;^UTILITY(U,$J,358.3,8299,2)
 ;;=^41396
 ;;^UTILITY(U,$J,358.3,8300,0)
 ;;=N45.3^^55^537^19
 ;;^UTILITY(U,$J,358.3,8300,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8300,1,3,0)
 ;;=3^Epididymo-orchitis
 ;;^UTILITY(U,$J,358.3,8300,1,4,0)
 ;;=4^N45.3
 ;;^UTILITY(U,$J,358.3,8300,2)
 ;;=^5015707
 ;;^UTILITY(U,$J,358.3,8301,0)
 ;;=N47.1^^55^537^53
 ;;^UTILITY(U,$J,358.3,8301,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8301,1,3,0)
 ;;=3^Phimosis
 ;;^UTILITY(U,$J,358.3,8301,1,4,0)
 ;;=4^N47.1
 ;;^UTILITY(U,$J,358.3,8301,2)
 ;;=^93340
 ;;^UTILITY(U,$J,358.3,8302,0)
 ;;=N47.6^^55^537^7
 ;;^UTILITY(U,$J,358.3,8302,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8302,1,3,0)
 ;;=3^Balanoposthitis
 ;;^UTILITY(U,$J,358.3,8302,1,4,0)
 ;;=4^N47.6
 ;;^UTILITY(U,$J,358.3,8302,2)
 ;;=^12530
 ;;^UTILITY(U,$J,358.3,8303,0)
 ;;=N48.1^^55^537^6
 ;;^UTILITY(U,$J,358.3,8303,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8303,1,3,0)
 ;;=3^Balanitis
 ;;^UTILITY(U,$J,358.3,8303,1,4,0)
 ;;=4^N48.1
 ;;^UTILITY(U,$J,358.3,8303,2)
 ;;=^12525
 ;;^UTILITY(U,$J,358.3,8304,0)
 ;;=N52.9^^55^537^40
 ;;^UTILITY(U,$J,358.3,8304,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8304,1,3,0)
 ;;=3^Male erectile dysfunction, unspecified
 ;;^UTILITY(U,$J,358.3,8304,1,4,0)
 ;;=4^N52.9
 ;;^UTILITY(U,$J,358.3,8304,2)
 ;;=^5015763
 ;;^UTILITY(U,$J,358.3,8305,0)
 ;;=N50.9^^55^537^13
 ;;^UTILITY(U,$J,358.3,8305,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8305,1,3,0)
 ;;=3^Disorder of male genital organs, unspecified
 ;;^UTILITY(U,$J,358.3,8305,1,4,0)
 ;;=4^N50.9
 ;;^UTILITY(U,$J,358.3,8305,2)
 ;;=^5015751
 ;;^UTILITY(U,$J,358.3,8306,0)
 ;;=R10.2^^55^537^51
 ;;^UTILITY(U,$J,358.3,8306,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8306,1,3,0)
 ;;=3^Pelvic and perineal pain
 ;;^UTILITY(U,$J,358.3,8306,1,4,0)
 ;;=4^R10.2
 ;;^UTILITY(U,$J,358.3,8306,2)
 ;;=^5019209
 ;;^UTILITY(U,$J,358.3,8307,0)
 ;;=N95.2^^55^537^55
 ;;^UTILITY(U,$J,358.3,8307,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8307,1,3,0)
 ;;=3^Postmenopausal atrophic vaginitis
 ;;^UTILITY(U,$J,358.3,8307,1,4,0)
 ;;=4^N95.2
 ;;^UTILITY(U,$J,358.3,8307,2)
 ;;=^270577
 ;;^UTILITY(U,$J,358.3,8308,0)
 ;;=Q61.3^^55^537^54
 ;;^UTILITY(U,$J,358.3,8308,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8308,1,3,0)
 ;;=3^Polycystic kidney, unspecified
 ;;^UTILITY(U,$J,358.3,8308,1,4,0)
 ;;=4^Q61.3
 ;;^UTILITY(U,$J,358.3,8308,2)
 ;;=^5018797
 ;;^UTILITY(U,$J,358.3,8309,0)
 ;;=R30.0^^55^537^14
 ;;^UTILITY(U,$J,358.3,8309,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8309,1,3,0)
 ;;=3^Dysuria
 ;;^UTILITY(U,$J,358.3,8309,1,4,0)
 ;;=4^R30.0
 ;;^UTILITY(U,$J,358.3,8309,2)
 ;;=^5019322
 ;;^UTILITY(U,$J,358.3,8310,0)
 ;;=R33.9^^55^537^58
 ;;^UTILITY(U,$J,358.3,8310,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8310,1,3,0)
 ;;=3^Retention of urine, unspecified
 ;;^UTILITY(U,$J,358.3,8310,1,4,0)
 ;;=4^R33.9
 ;;^UTILITY(U,$J,358.3,8310,2)
 ;;=^5019332
 ;;^UTILITY(U,$J,358.3,8311,0)
 ;;=R32.^^55^537^68
 ;;^UTILITY(U,$J,358.3,8311,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8311,1,3,0)
 ;;=3^Urinary Incontinence,Unspec
 ;;^UTILITY(U,$J,358.3,8311,1,4,0)
 ;;=4^R32.
 ;;^UTILITY(U,$J,358.3,8311,2)
 ;;=^5019329
